IMNM - Immunome  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMNM is currently covered by 4 analysts with an average price target of $19.28. This is a potential upside of $10.3 (114.7%) from yesterday's end of day stock price of $8.98.

Immunome 's activity chart (see below) currently has 6 price targets and 14 ratings on display. The stock rating distribution of IMNM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48% with an average time for these price targets to be met of 87.4 days.

Highest price target for IMNM is $33, Lowest price target is $21, average price target is $21.5.

Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 14-Nov-2024. First documented stock forecast 20-Aug-2021.

Best performing analysts who are covering IMNM - Immunome :

Matthew Barcus David Nierengarten Brian Cheng Geulah Livshits Biren Amin

Currently out of the existing stock ratings of IMNM, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$11.6 (123.40%)

$23

3 months 18 days ago
(14-Nov-2024)

0/3 (0%)

$9.86 (88.51%)

Buy

$33

$23.6 (251.06%)

$33

4 months 7 days ago
(25-Oct-2024)

2/5 (40%)

$20.89 (172.50%)

14

Buy

$24

$14.6 (155.32%)

$33

10 months 2 days ago
(30-Apr-2024)

0/3 (0%)

$9.94 (70.70%)

Buy

$8

$-1.4 (-14.89%)

$9

1 years 11 months 15 days ago
(17-Mar-2023)

3/3 (100%)

$2.31 (40.60%)

398

Buy

$21

$12.65 (151.50%)

3 years 6 months 12 days ago
(20-Aug-2021)

1/1 (100%)

$8.5 (68.00%)

25

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMNM (Immunome ) average time for price targets to be met?

On average it took 87.4 days on average for the stock forecasts to be realized with a an average price target met ratio 48

Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on IMNM (Immunome ) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on IMNM (Immunome )?

Matthew Barcus has 5 price targets and 6 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome )?

David Nierengarten with highest potential upside - $23.6

Which analyst is the currently most reserved on IMNM (Immunome )?

Matthew Barcus with lowest potential downside - -$1.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?